A Novel Blood Proteomic Signature for Prostate Cancer

A Novel Blood Proteomic Signature for Prostate Cancer

Prostate cancer is the most common malignant tumour in men. Improved testing for diagnosis, risk prediction, and response to treatment would improve care. Here, we identified a proteomic signature of prostate cancer in peripheral blood using data-independent acquisition mass spectrometry combined wi...

Full description

Bibliographic Details
Main Authors: Ammara Muazzam, Matt Spick, Olivier N. F. Cexus, Bethany Geary, Fowz Azhar, Hardev Pandha, Agnieszka Michael, Rachel Reed, Sarah Lennon, Lee A. Gethings, Robert S. Plumb, Anthony D. Whetton, Nophar Geifman, Paul A. Townsend
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cancers
Subjects:
prostate cancer
clinical onset
biomarkers
proteomics
SWATH-MS
complement cascade
Online Access:https://www.mdpi.com/2072-6694/15/4/1051

Internet

https://www.mdpi.com/2072-6694/15/4/1051

Similar Items